The treatment of Backache & Glaucoma with vitamins

Backache and Glaucoma: Mitamins custom make quality formulas for the treatment of Backache & Glaucoma with vitamins. A Backache & Glaucoma formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Backache and Glaucoma

  • Amount Per Serving
    % DV
    Vitamin C
    200
    mg
    333%
    Vitamin B12
    50
    mcg
    833%
    Calcium
    50
    mg
    5%
    Magnesium
    25
    mg
    6%
    Zinc
    10
    mg
    67%
    Potassium
    50
    mg
    1%
    Alpha Lipoic Acid
    50
    mg
    *
    Bilberry Extract
    50
    mg
    *
  • Amount Per Serving
    % DV
    Feverfew Extract
    50
    mg
    *
    Ginkgo Extract
    40
    mg
    *
    Green Tea Extract
    50
    mg
    *
    L-Arginine
    100
    mg
    *
    DL-Phenylalanine
    100
    mg
    *
    White Willow Extract
    30
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice

Backache and Glaucoma Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
GSK Submits Cervarix? Licence Application To Japan's Health Authorities
GlaxoSmithKline (GSK) announced that it has submitted a licence application for its cervical cancer candidate vaccine Cervarix? to the Japanese Ministry of Health, Labor and Welfare (MHLW). This is the first vaccine for the prevention of cervical cancer to be filed for approval in Japan.GSK's cervical cancer candidate vaccine is formulated with a novel proprietary adjuvant system called AS04, intended to enhance immune response and increase duration of protection.
EMEA approves new starting dose for SPRYCEL in chronic myeloid leukaemia
Bristol-Myers Squibb Pharmaceuticals Limited (Bristol-Myers Squibb) announced the European Commission has approved an update to the summary of product characteristics for Sprycel® (dasatinib). The label now specifies 100 mg once-daily as a starting dose for patients with chronic phase chronic myeloid leukaemia (CML) that is resistant or intolerant to prior therapy, including imatinib.
This information concerning the support of Backache and Glaucoma treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments